Clinical Trials Directory

Trials / Completed

CompletedNCT05063747

Long Term Outcome in ICU Treated COVID-19: Risk Factors for 1-year Mortality

Status
Completed
Phase
Study type
Observational
Enrollment
13,537 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mortality within one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed. Risk and risk factors for one year mortality in ICU patients will be compared to patients admitted to hospital with COVID-19 and general population controls. The ICU population comprises all Swedish ICU patients with COVID-19 with at lease one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region. ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on socioeconomics and income are provided by the Statistics Sweden. Data on comorbidity, medications and death are provided from the National board of health and welfare.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention.Observational study. No intervention.

Timeline

Start date
2021-10-15
Primary completion
2021-11-15
Completion
2021-11-15
First posted
2021-10-01
Last updated
2022-05-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05063747. Inclusion in this directory is not an endorsement.